Verus Announces Presence With $98M Series A Round June 10, 2005 By Brady Huggett Verus Pharmaceuticals Inc., a company with no technology platform, no products and no plans for R&D, raised total funding of $98 million in its Series A round. (BioWorld Today)Read More
RSS